Pharmafile Logo
Pharmafocus logo
Advanced Search

age-related macular degeneration

Showing 3 posts of 3 posts found.

PulseSight Therapeutics closes Series A financing for dry AMD phase 1 clinical study

February 14, 2025
Clinical Research Opthalmology, age-related macular degeneration, clinical trials

Ophthalmology biotech PulseSight Therapeutics has confirmed the closure of its Series A funding round, the proceeds of which will be …

News
eye2

Common diabetes drug can protect against age-related macular degeneration, research shows

October 31, 2018
Research and Development age-related macular degeneration, diabetes, eye, metformin, pharma

A Taiwanese research team has demonstrated a link between the use of the common diabetes medication metformin and significantly lower …

News
Age-related macular degeneration (Wet AMD)

Bayer’s challenger to Lucentis shows promise

November 22, 2010
Research and Development, Sales and Marketing Bayer, Lucentis, Novartis, Regeneron, Roche, VEGF Trap-Eye, age-related macular degeneration, avastin, wet AMD

Phase III data for a new age-related macular degeneration (wet AMD) treatment show it is as good as Lucentis, the …

News
The Gateway to Local Adoption Series

Latest content

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026